Tesofensine (250mcg) / Dihexa (10mg) x 60 Tablets Oral solid-form research compound formulated for controlled analytical and investigational applications
Symptoms of Poor Healing: Slow closure of wounds, formation of thick, keloid, or hypertrophic scars, and persistent tenderness
If you have used them and feel unwell or have concerns, talk to a healthcare professional right away
Anti-Inflammatory Effects: Reduces inflammation, which is beneficial in treating chronic inflammatory skin conditions
Its stability-enhancing N-terminal modification allows for effective subcutaneous administration, and it is FDA-approved for HIV-related lipodystrophy
In the Lancet 2021 Phase 2 trial at 4.5 mg/week, nausea occurred in 47% of participants, injection-site reactions in 43%, constipation in 21%, and vomiting in 8%